GLP-1 Case Study Name: Richard J., a 58-year-old male Medical History: Type 2 Diabetes Mellitus (diagnosed 7 years ago) Obesity (BMI 35 kg/m) Hypertension (well-controlled on an ACE inhibitor) Mild diabetic retinopathy Current Medications: Metformin 1000 mg twice daily, glimepiride 2 mg once daily, and lisinopril 20 mg once daily Clinical Presentation Richard presents a routine follow-up
Additionally, hypoglycaemia (low blood sugar), though less common with GLP-1 agonists than with insulin or sulphonylureas, can cause irritability, confusion, and mood changes when it does occur, particularly in patients taking concurrent diabetes medications
VitaStir sources from licensed compounding pharmacies, which is the baseline expectation
doi: 10.3389/fendo.2020.601290 Received 31 August 2020 Accepted 12 November 2020 Published 14 December 2020 Volume 11 - 2020 Edited by Magdalene K
Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies